Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    

| More

Thermax - Q1FY21 First Cut - ICICI Securities

Posted On: 2020-08-12 09:05:25

(CMP: Rs. 749; MCap: Rs. 8,925 crore)

Thermax reported weaker Q1FY21 performance with substantial decline in revenue owing to muted order book and covid-19 impact. Consequently, it reported loss at EBITDA level and margins further deteriorated. However, order inflows and order book continue to remain key concerns amid slowdown in industrial activities.

Q1FY21 Earnings Summary

Consolidated revenue came in at Rs. 665 crore registering decline of 52.2% YoY (Vs our estimate of Rs. 716.4 crore) on the back of slower execution owing to covid-19 lockdowns. Energy segment revenue (which contributes ~75% to revenue) declined by 57% to Rs. 500.4 crore, YoY while Environment segment revenue declined by 43% to Rs. 83.9 crore and chemical segment revenue came in at Rs. 84.3 crore, down 13.8%, YoY.

The consolidated order inflow for the quarter came in at Rs. 608 crore down 50% on YoY basis. While consolidated order book as on Q1FY21 stood at Rs. 5212 crore, down 1.0% on YoY basis.

The company has registered a loss of Rs. 11.4 crore at EBITDA level (Vs. EBITDA of Rs. 99.1 crore in Q1FY20), owing to higher employee expenses, other operating expenses and lesser booking of revenues.

Consolidated loss after tax came in at Rs. 15.3 crore (vs. PAT of Rs. 62.8 crore in Q1FY20), partially impacted by 6.8% YoY increase in depreciation.

Thermax' weak execution performance was reflection of subdued order inflows and order backlog and disruption in dispatches & execution amid lockdowns while margins further deteriorated due to higher operating expenses amid Covid-19.

We would be coming out with a detailed report post the conference call.

Shares of THERMAX LTD. was last trading in BSE at Rs.749 as compared to the previous close of Rs. 736.5. The total number of shares traded during the day was 11624 in over 3938 trades.

The stock hit an intraday high of Rs. 749.8 and intraday low of 735. The net turnover during the day was Rs. 8599556.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot

Bharat Forge - Expectation hurdle remains steep - ICICI Securities


Mutual Fund Review - September, 2020 - ICICI Securities

UTI AMC announces IPO date - Angel Broking

Asian Paints - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Britannia Industries - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Hexaware Technologies (Not Rated): Hexaware accepts 475/share as final delisting price - ICICI Securities

CAMS IPO - Day 2 Subscription - Angel Boking

Chemcon Speciality Chemicals - IPO subscribed 12.62 times on second day - Angel Broking

General insurance - Fire, health remain growth drivers, rising Covid claims a concern - ICICI Securities

Supreme Industries - Perfect recipe for rerating; upgrade to BUY - ICICI Securities

Titan Company - Best positioned to gain from faster-than-expected recovery. Upgrade to ADD - ICICI Securities

Sector Update - Telecom - Sep 23, 2020 - ICICI Securities

Allcargo Logistics - Highlights of Blackstone deal - ICICI Securities

I-direct Instinct - Gokaldas Exports

Economy: RBI's trilemma: allows for INR strength - Kotak

HCL Technologies - Company Update - ICICI Securities

Chemcon Speciality Chemicals - IPO Review - ICICI Securities

Angel Broking - IPO Note - YES Securities

TCS - Announcement of its blockhchain based solutions on Microsoft Azure - Angel Broking

Amber Enterpirses acquire Sidwal - Angel Broking

Dixon Technologies - Buy - YES Securities

HCL Technologies acquisition of DWS Limited - Angel Broking

Allcargo Logistics CFO Resignation - Angel Broking

Upgrade to BUY on Gateway Distriparks - Strengthening the balance sheet - HDFC Securities

BUY on ITD Cementation - Execution pickup awaited - HDFC Securities

Allcargo Logistics - Trying to stich through an integrated offering - ICICI Securities

Polymer price tracker - Other polymer (ex-PVC) prices too firm up - ICICI Securities

Angel Broking - IPO Review - ICICI Securities

IPO Review - Computer Age Management Services - ICICI Securities

Company Update - EIH Ltd - ICICI Securities

Gladiator Stocks - Godrej Properties - ICICI Securities

Company Update - Dr Reddy's Laboratories - ICICI Securities

Gladiator Stocks: Pharma Thematic - ICICI Securities

Company Update - Housing & Urban Development - ICICI Securities

Covid Recovery Pulse - E-Way bill generation shows recovery signs with auto volumes flat - ICICI Securities

Quant Pick - UltraTech Cement - ICICI Securities

Lupin & Cipla - Positive News - Angel Broking

Sterling and Wilson Solar Ltd - 106.71 MW order win - Angel Broking

Dr. Reddy's Laboratories - Settles Revlimid litigation in US - ICICI Securities

Natco Pharma - Natco to launch first generic Revlimid - ICICI Securities

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019